Stock Market News
Alabama settles opioid claims against J&J, distributors for $276 million – attorney general
2022.04.19 21:16
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid
(Reuters) – Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corp (NYSE:MCK) and Endo Pharmaceutical, resolving the state’s claims that the companies fueled an opioid addiction crisis, the state Attorney General said.